<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 5-year incidence of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) and progression to overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> was investigated in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> who had <z:mp ids='MP_0002959'>microalbuminuria</z:mp> with (MA+R group, n=93) or without (MA-R group, n=138) diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The rate of progression to overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> was higher in the MA+R group than in the MA-R group </plain></SENT>
<SENT sid="2" pm="."><plain>The MA-R group had more components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> than the MA+R and normoalbuminuric (NA, n=205) groups </plain></SENT>
<SENT sid="3" pm="."><plain>The MA-R group had a higher 5-year incidence of CAD than the NA group </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence of CAD tended to be higher in the MA-R group than in the MA+R group, but statistical significance was not reached </plain></SENT>
<SENT sid="5" pm="."><plain>The present study shows that patients with diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> represent a group with incipient diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> having higher risk for progression to overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>On the other hand, patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and no <z:hpo ids='HP_0000488'>retinopathy</z:hpo> may represent a group with characteristics of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>